Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.090
-0.050 (-1.59%)
At close: Jun 26, 2026, 4:00 PM EDT
3.500
+0.410 (13.27%)
After-hours: Jun 26, 2026, 5:14 PM EDT
Evaxion Market Cap
Evaxion has a market cap or net worth of $25.77 million as of June 26, 2026. Its market cap has increased by 41.17% in one year.
Market Cap
25.77M
Enterprise Value
7.33M
1-Year Change
41.17%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $25.77M, a decrease of -86.58%. That is a compound annual growth rate of -31.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 25.77M | -35.22% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 29.19M |
| Plus Therapeutics | 28.91M |
| Vistagen Therapeutics | 28.80M |
| Barinthus Biotherapeutics | 28.59M |
| Serina Therapeutics | 27.15M |
| NeuroSense Therapeutics | 26.77M |
| BriaCell Therapeutics | 26.67M |
| IGC Pharma | 26.32M |